InnoSpring Seed Fund II has been backed by Legend, IDG, and SoftBank.

Adrenergics, CadheRx and Calporta are each set to receive up to $10m in series A funding from GlaxoSmithKline and Avalon Ventures.

Johns Hopkins spin-out Gemstone Biotherapeutics secures $2.45m seed round for wound treatments.

Seattle Genetics committed $5m to the round earlier this week when the two companies signed a partnership agreement.

Wisconsin-Madison launches Ab E Discovery to develop antibiotic-free technology to prevent farmyard animal infections.

Leicester and Nottingham unis collaborate on Gamma Technologies to bring handheld gamma imaging to tumour surgery.